Top-News

Novo-Nordisk Aktie (ADR) News

Aktie
WKN:  866931 ISIN:  US6701002056 US-Symbol:  NVO Branche:  Pharmazeutika Land:  Dänemark
47,86 $
-0,13 $
-0,27%
41,103 € 05.12.25
Depot/Watchlist
Marktkapitalisierung *
139,95 Mrd. €
Streubesitz
89,76%
KGV
27,28
Dividende
0,58 $
Dividendenrendite
1,22%
Faktor
1
Originalaktie
DK0062498333
Weiter abwärts? Short handeln - Jetzt mit Hebel 19,84: MM7X9J
Werbung

Novo-Nordisk Aktie (ADR) News

04.02.25 - PR Newswire
Shareholders that lost money on Novo Nordisk A/S(NVO) should contact Levi & Korsinsky about pending Class Action - NVO
Shareholders that lost money on Novo Nordisk A/S(NVO) should contact Levi & Korsinsky about pending Class Action - NVO PR Newswire
03.02.25 - PR Newswire
March 25, 2025 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against NVO
March 25, 2025 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against NVO PR Newswire
31.01.25 - PR Newswire
NVO INVESTOR DEADLINE: Novo Nordisk A/S Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
NVO INVESTOR DEADLINE: Novo Nordisk A/S Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit PR Newswire
31.01.25 - PR Newswire
Shareholders that lost money on Novo Nordisk A/S(NVO) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
Shareholders that lost money on Novo Nordisk A/S(NVO) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More PR Newswire
30.01.25 - PR Newswire
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Novo Nordisk
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Novo Nordisk PR Newswire
30.01.25 - PR Newswire
NVO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Novo Nordisk A/S Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
NVO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Novo Nordisk A/S Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit ...
30.01.25 - PR Newswire
NVO LAWSUIT ALERT: The Gross Law Firm Notifies Novo Nordisk A/S Investors of a Class Action Lawsuit and Upcoming Deadline
NVO LAWSUIT ALERT: The Gross Law Firm Notifies Novo Nordisk A/S Investors of a Class Action Lawsuit and Upcoming Deadline PR Newswire
28.01.25 - PR Newswire
NVO Investors Have Opportunity to Lead Novo Nordisk A/S Securities Fraud Lawsuit
NVO Investors Have Opportunity to Lead Novo Nordisk A/S Securities Fraud Lawsuit PR Newswire
28.01.25 - PR Newswire
Novo Nordisk A/S Sued for Securities Law Violations - Contact Levi & Korsinsky Before March 25, 2025 to Discuss Your Rights - NVO
Novo Nordisk A/S Sued for Securities Law Violations - Contact Levi & Korsinsky Before March 25, 2025 to Discuss Your Rights - NVO PR Newswire
28.01.25 - PR Newswire
NVO Investors Have Opportunity to Lead Novo Nordisk A/S Securities Fraud Lawsuit with the Schall Law Firm
NVO Investors Have Opportunity to Lead Novo Nordisk A/S Securities Fraud Lawsuit with the Schall Law Firm PR Newswire
27.01.25 - PR Newswire
NVO INVESTOR ALERT: Novo Nordisk A/S Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
NVO INVESTOR ALERT: Novo Nordisk A/S Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit PR Newswire
27.01.25 - PR Newswire
Stockholder Alert: Robbins LLP Informs Investors of the Novo Nordisk A/S Class Action
Stockholder Alert: Robbins LLP Informs Investors of the Novo Nordisk A/S Class Action PR Newswire
20.01.25 - LYNX Analysen
Novo Nordisk: Noch kein Licht am Ende des Tunnels
Die Aktie des dänischen Pharmaunternehmens hat mit Sicherheit schon bessere Zeiten gesehen. Und das letzte Halbjahr würden Anleger wohl am liebsten vergessen. Jetzt ...
12.01.25 - Boersia.de
Novoordisk A/S Aktie: Ein weiterer Durchbruch erreicht!
Die Novo Nordisk A/S verzeichnete am 10. Januar 2025 eine erfreuliche Kursentwicklung mit einem Plus von 0,56 Prozent und einem Schlusskurs von 86,13 USD. Der ...
14.12.24 - Börse-Global
Novoordisk A/S Aktie: Investorenerwartungen übertroffen
Die Novoordisk A/S Aktie verzeichnete am 14. Dezember 2024 einen leichten Rückgang von 1,54 Prozent auf 106,96 USD. Der dänische Pharmakonzern, der sich auf Diabetes- und ...
08.12.24 - Boersia.de
Novoordisk A/S Aktie: Spannende Zeiten voraus!
Die Novoordisk A/S verzeichnet zum Ende des Jahres 2024 eine beständige Marktposition mit einer beachtlichen Marktkapitalisierung von 352,8 Milliarden Euro. Der aktuelle ...

Newssuche

Videos

newspaper
06.12.25
Master the Trading!
In diesem Trading-​Webinar haben wir von A bis Z den Aufbau professionellen Tradings thematisiert und ... Mehr »